CAR-NK Technologies
CAR-NK therapy builds upon allogeneic NK Cells (“Natural Killer”) providing the NK cells with the information necessary to recognize, target, and destroy cancer cells. CAR-NK technology is proving to be a superior alternative to CAR-T, with many advantages such as multifunctionality, low toxicity, and universal patient applications, i.e., not patient-specific.
Cellicure’s Solution
Based on NK biology and NK receptor signaling properties, Cellicure has developed the “Complete Signaling CAR (csCAR)” solution. This innovative technology overcomes the challenges of the receptor cell barrier by deploying the patented and innovative signal 3 and 4 elements as well as our own hinge and transmembrane domain.
OUR TECHNOLOGIES
Cellicure’s Solutions
Cellicure's proprietary systems deliver high-yield NK cell treatments engineered to maximize efficacy while minimizing toxicity across multiple cancer types and inflammatory conditions.
Effic-NK™ expansion
Feeder-free system producing clinical-grade NK cells with enhanced expansion and reduced manufacturing complexity.
Saftein™ technology
Proprietary safety mechanism designed to improve NK cell survival and function while eliminating cytokine-related toxicity.
Solid tumor targeting
Engineered immunotherapies specifically developed to penetrate and destroy solid tumor microenvironments effectively.
Hematological cancer focus
Tailored NK cell treatments addressing blood cancers with precision activation and selective tumor cell recognition.